Summary. The feasibility of disease association studies using polymorphic DNA markers in the tyrosine hydroxylase/insulin/insulin-like growth factor II chromosomal region was indicated by a high degree of linkage disequilibrium found in haplotypes. Haplotypes were resolved in the parents from Scandinavian nuclear families by studying the segregation of eight DNA polymorphisms. Comparison of observed vs expected frequencies of haplotypes, as well as pairwise measures of linkage disequilibrium, indicated a high degree of linkage disequilibrium. Five restriction fragment length polymorphisms linked to the tyrosine hydroxylase/insulin/ insulin growth factor II region of chromosome 11 were investigated in relation to Type 2 (non-insulin-dependent) diabetes mellitus, and to glucose and insulin responses to glucose infusion in healthy subjects. No significant differences in genotype frequencies between Type 2 diabetic (n = 53) and healthy subjects (n = 106) were found. A significant association (p < 0.001) was initially found between genotypes defined by a PstI polymorphism located 5' of the tyrosine hydroxylase gene and the early glucose response to a standardized glucose infusion test in healthy subjects. However, a follow-up study of 112 healthy individuals failed to confirm this finding.
Type 2 (non-insulin-dependent) diabetes mellitus is a common, heterogeneous disorder with a multifactorial aetiology, including a strong genetic component [1] [2] [3] [4] . Several studies have suggested that impaired insulin secretion is an early defect in the development of the disease [5] [6] [7] [8] , and it has been shown that insulin release is genetically regulated [9] . Contributions of deficiencies in insulin gene function for impaired insulin secretion, and for the development of Type 2 diabetes can be addressed by population association studies. Association studies have hitherto been mainly focused on a variable number of tandem repeat (VNTR) polymorphism located near the 5" end of the insulin gene. The conclusion of these studies is that no association can be found between this DNA polymorphism and manifest Type 2 diabetes [10, 11] . However, a study of healthy Italian subjects had suggested an association between the long alleles of the VNTR polymorphism and a reduced ability, following glucose infusion, to secrete insulin [12] .
Establishment of linkage disequilibrium in a chromosomal region is important for determining the feasibility of disease association studies between susceptibility genes and DNA markers. The tyrosine hydroxylase (TH), insulin (INS), and insulin-like growth factor II (IGF-II) genes are located within 55 kilobase pairs (kb) on the short arm of chromosome 11 [13, 14] . Earlier studies of finkage equilibrium relationships in this region have shown conflicting results [15, 16] .
In previous studies, multiple DNA polymorphisms in the TH/INS/IGF-II chromosomal region have been examined in mixed Caucasian or Chinese American populations [15] [16] [17] . The studies of Cox et al. [16] and Xiang et al. [17] were based on statistically deduced haplotypes. In the present study, we have used family data to deduce the haplotypes in the genetically homogenous Scandinavian population. These haplotypes were used to determine the degree of linkage disequilibrium in the TH/INS/IGF-II chromosomal region. Furthermore, we have examined whether multiple DNA polymorphisms in the insulin gene region are associated with Type 2 diabetes or with variations in glucose and insulin responses to a standardized glucose infusion test in healthy subjects. Values are means with ranges within parentheses
Subjects and methods

Subjects
For the haplotype analysis, a total of 209 subjects from 54 Scandinavian nuclear families were studied. Genotypes were determined in an additional group of 58 unrelated Scandinavians; 9 male patients with Type 2 diabetes (8 treated with diet, i treated with oral hypoglycaemic therapy) and 49 healthy individuals (36 males and 13 females). Characteristics of the groups used in the genotype analysis are summarized in Table 1 . Mainly non-obese diabetic subjects were chosen (45 out of 53 had BMI < 28), since genetic factors have been found to be more prominent in non-obese than in obese Type 2 diabetes subjects [2] . Type2 diabetes was diagnosed according to the World Health Organization criteria, as described earlier [18] . The healthy individuals all had a fasting blood glucose of less than 5.2 mmol/1. The follow-up study of the PstI-A polymorphism comprised 112 healthy unrelated Scandinavian men, mean age 36.7 years (range 20-47), mean BMI 23.8 kg/m 2 (range 17.2-30.0), mean fasting glucose 4.4 mmol/1 (range 3.1-5.1). All participating individuals gave informed consent to this study, which was conducted with the approval of the Ethics Committee at the Karolinska Hospital.
Glucose infusion test
The glucose infusion test was performed in the morning after 8-12 h of fasting. A rapid injection of 500 mg glucose per kg body weight was immediately followed by a glucose infusion at a rate of 20 mg. kg-1. min-i for 60 min. Venous blood samples were drawn at 0, 5, 10, 20, 30, 40, 50, 60, 80, 100, and 120 min for determination of glucose and immunoreactive insufin (IRI) [19] .
DNA analysis
The DNA polymorphisms studied and the probes used are listed in Table 2 [20] [21] [22] [23] [24] [25] . DNA isolated from peripheral leukocytes [26] was digested with restriction enzymes PstI, RsaI, DraI, TaqI, PvuII, BamHI, or SacI, and analysed by Southern blotting [27] as previously described [18] . The genomic clones phINS 500, phINS-1, )~HI-2 and phINS 311, as well as the cDNA clone phIGF2 were kindly provided by Dr. G.I. Bell, University of Chicago (Chicago, Ill., USA). The clone phINS E-22 is a subcloned EcoRI 2.2 kb fragment from %HI-2, the clone phINS 12-31 is a subcloned 721 base pair bp) PvuII/PvuII fragment of phINS-1, and 500-5 is a PstI/PstI fragment of 0.5 kb isolated from phINS 500 (Fig. 1) . The 3-allele PstI-A polymorphism is M. Sten-Linder et al.: Insulin gene region RFLPs and glucose/insulin response the result of two polymorphic sites. There are no indications of a VNTR polymorphism giving rise to the three PstI alleles, since the 500-5 probe did not reveal a VNTR polymorphism with any of 10 other enzymes tested (BamHI, BglII, DraI, EcoRI, HindIII, KpnI, RsaI, SacI, TaqI, XbaI). The follow-up study of the PstI-A polymorphism was conducted with PstI digestion of polymerase chain reaction products generated by amplification of genomic DNA by primers TH1 5'-GCCATGCAGAGCTTCACCAG-3' and TH2 5'-CTGCTFGGCGTCCAGCTCAG-3'. Amplification of 200 ng genomic DNA using 0.5 gmol/1 of each primer was performed. After an initial denaturation at 96~ for 3 rain, 30 cycles were performed, including denaturation at 96 ~ for I rain, primer annealing at 60 ~ for 30 s, and primer extension at 72~ for 15 rain. The polymerase chain reaction buffer contained 1.0 mmol/1 MgC12, 0.2 mmol/1 of each of the four deoxynucleotide triphosphates (dATP, dCTP, dGTP and dTTP), 50 mmol/1KC1,10 mmol/l Tris-HClpH 8.4 at 70 ~ and 0.1% Tween 20. Two units Taq polymerase (Perkin-Elmer Cetus,Norwalk, Conn., USA) were used for each 100 gl reaction.
Statistical analysis
Comparison between observed and expected haplotype frequencies, as well as the comparison of haplotype distributions in diabetic vs normal chromosomes, were performed using chi-square analysis. Cells with expected numbers less than four were pooled to one group.
The values of the linkage disequilibrium parameter D' (D' = D/Dm~) and the chi-square tests on D were calculated as earlier described [28] [29] [30] . In our calculations D' is positive when two long alleles are associated and negative when the long allele at one locus is associated with the short allele at the second locus (except for the VNTR where allele i is the short allele). The level p < 0.005 was considered as the minimum requirement for significance in order to adjust for multiple comparisons.
Genotype frequencies of the diabetic and control subjects were compared using 2 • 3 or 2 x 2 contingency tables and chi-square analysis of independence. In these analyses, cells with expected numbers less than four were pooled to one group.
The amounts of glucose and IRI secreted between 0-10 rain, 10-60 min, and 60-120 rain during the glucose infusion test were determined as the areas under the concentration curves for each time period. In order to reduce skewness, some variables were logarithmically transformed prior to statistical analysis. The variables were then adjusted using stepwise multiple regression on age, sex, and in a second step, BMI. Only significant terms (p < 0.05) were retained in the regression equation. One-way analysis of variance or Student's t-test was performed on the adjusted variables, to test the null hypothesis that TH/INS/IGF-II genotypes are not associated with variations in glucose and insulin responses to glucose infusion test in healthy subjects. In order to compensate for multiple comparisons, p < 0.005 was chosen as the minimum requirement for significance in the initial study comprising several RFLP systems.
Results
DNA polymorphisms in the TH/INS/IGF-H chromosomal region
Eight DNA markers distributed over 50 kb in the TH/INS/IGF-II gene region of chromosome 11 were used in the haplotype analysis ( Table 2 , Fig. 1 ). Four of the markers, the RsaI, PstI-A, TaqI, and DraI RFLPs, are located within a few kb in the 5' flanking region of the TH gene [21, 25] . The two longer PstI-A alleles were considered as one allele, since with our probes, the presence of a short allele prevents the analysis of the second polymorphic site. The PstI-B, BamHI, and SacI sites were localized within the region by multiple probing and comparison to the known DNA sequences (Fig.l) . The VNTR polymorphism is located 363 bp 5' of the insulin gene transcription initiation site [20] . The rare TaqI allele 3 (2.8 kb) with a missing 2.0 kb band, was suspected to be the result of a deletion 5' of the gene, but pHINS 500 detected no abnormal fragment patterns with ten other enzymes (BamHI, BglII, DraI, EcoR1, HindIII, KpnI, PstI, RsaI, SacI, XbaI). The nondiabetic father and two children carrying this allele were all healthy.
Determination of haplotype frequencies
Haplotypes for the DNA markers were determined in unrelated parents of Scandinavian nuclear families using the offspring genotypes with the assumption that no recombination occurred in the families between these markers. There were no indications of non-paternity with the eight markers tested, or by the segregation of insulin receptor 27 gene haplotypes with 34 different alleles [30] . Complete haplotypes were successfully determined for 84 individuals (34 diabetic and 50 healthy subjects). Twenty-three different complete haplotypes were observed (Table 3) . The DraI and RsaI RFLPs showed a complete linkage disequilibrium with Pst-A in these individuals, and was therefore excluded in the further analyses.
The overall haplotype distribution of Type 2 diabetes and normal chromosomes was compared using chi-square analysis. Prior to analysis, all but the six most common groups (haplotype no. 3, 4, 13, 14, 20 and 22) were pooled in order to achieve cells with expected frequencies of at least four, thus the chi-square analysis is insensitive. No significant difference in haplotype distribution between Type 2 diabetes and normal chromosomes was detected 0{ 2 = 4.40, 6 dr).
Estimation of linkage disequilibrium in the TH/INS/IGF-H chromosomal region
The expected haplotype frequencies -assuming linkage equilibrium-were calculated as the product of their compound marker allele frequencies in the healthy parents included in the haplotype study. The level of overall linkage disequilibrium was estimated by chi-square analysis of the observed vs the expected haplotype frequencies. All cells with expected numbers less than four in either normal or Type 2 diabetes chromosomes were pooled to one group prior to the analysis. The observed frequency distribution of the haplotypes in both healthy subjects (Z 2 = 14.25, 4 dr, p < 0.01) and Type 2 diabetic patients (Z2= 15.31, 4 dr,, p < 0.005) differed significantly from the expected distribution, suggesting overall linkage disequilibrium in the TI-I/INS/IGF-II chromosomal region.
The parameter D' was determined to obtain measures of linkage disequilibrium between RFLP pairs (Table 4) . Data from both complete and partial haplotypes were used for these calculations. The rare TaqI 3-allele and the VNTR 2-allele were excluded in these analyses. The TaqI:BamHI pair and the PstI-B:SacI pair showed significant: linkage disequilibrium in chromosomes from both normal and Type 2 diabetic subjects, despite the relatively large physical distance between these markers. Significant linkage disequilibrium was also detected between most of the adjacent RFLP sites.
We conclude from these studies that, since the TH/INS/ IGF-I.I gene region shows a high degree of linkage disequilibrium, DNA polymorphisms in this region can be used in disease association studies of this population.
Genotype distribution in Type 2 diabetic patients and healthy subjects
We used an enlarged study group of Type 2 diabetic patients (n--53) and healthy control subjects (n = 106) ( Table 1) for the analysis of genotype distribution. Five DNA polymorphisms distributed over the gene region were selected for the analysis. The distribution of these RFLP genotypes are shown in 
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RsaI PstlATaqI DraI shown by the vertical arrows. The 3-allele system generated by PstI-A is composed of two polymorphic sites, the site used in our analysis is denoted by an arrow. The second PstI-A site is located approximately i kb 5' of this site. Information for this figure was obtained from [14, 21, 
Glucose and insulin responses to glucose infusion in different genotype groups of healthy subjects
The possible association between TH/INS/IGF-II RFLP genotypes and variations in glucose and insulin responses to glucose infusion in healthy subjects was investigated. We compared the insulin and glucose concentrations during a standardized glucose infusion test between the difTable3. Frequencydistributionofthetyrosinehydroxylase/insulin/insulin-likegrowthfactor II (THflNS/IGF-II)regionhaplotypesinType 2 (non-insulin-dependent) diabetic patients and healthy subjects. Expected values assuming equilibrium were calculated as the products of the frequencies of composite alleles in the healthy subjects a The TaqI 1/1, 1/2, and 1/3 genotypes were pooled before performing the chi-square analysis in order to achieve an expected number of at least four in all groups ferent genotype groups. The amounts of glucose and insulin were calculated as the areas under the concentration curves during different time periods of the test (Tables 6  and 7 ). Prior to statistical analysis, the variables were adjusted for effects associated with age, sex or BM1. The values from the glucose infusion test in the different genotype groups were compared using one-way analysis of variance or Student's t-test. In order to compensate for multiple comparisons, p < 0.005 was chosen as the minimum requirement for significance. One association between genotypes and glucose infusion test variables was found at this level of significance. Subjects with different PstI-A genotypes displayed a small but highly significant difference in the plasma glucose levels attained during the first 10 min of infusion (p < 0.00l) . (Table 6 ). Significant differences in insulin (IRI) concentrations for the same time period were not observed ( Table 7) . The reproducibility of the significant difference in the initial plasma glucose levels during glucose infusion in subjects with different PstI-A genotypes was tested in a follow-up study of 112 unrelated, healthy male subjects with fasting glucose below 5.2 mmol/1 (see Subjects and methods for clinical characteristics). The same standardized glucose infusion test was performed on this group as for the subjects in the initial study. In contrast to the significant finding above, no significant differences in glucose or insulin concentrations during glucose infusion was found between the different PstI-A genotype groups (Table 8) .
Discussion
The present study indicates a high degree of linkage disequilibrium in the TH/INS/IGF-II chromosomal region in the Scandinavian population. An almost total linkage disequilibrium was observed for three of the four RFLPs which are located physically close to each other 5' of the TH gene (PstI-A, RsaI and DraI). The fourth RFLP (TaqI) in this cluster shows a somewhat weaker linkage disequilibrium. Since the TaqI 1-allele is relatively rare and is present on two similar haplotypes only, the TaqI polymorphism may be evolutionary more recent than the other polymorphisms in this chromosomal region. The TaqI:BamHI pair and the PstI-B:SacI pair showed significant linkage disequilibrium in chromosomes from both normal and Type 2 diabetic subjects, despite the relatively large physical distance between these markers. These observations suggest the absence of a high recombination rate in the INS 5' VNTR, in accordance with the finding that VNTR polymorphisms show no increased interchromosomal recombination [31] . Our findings are in agreement with the study of Cox et al. [16] , and support the conclusion that the use of population association studies to study correlations between markers from the TH/INS/IGF-II locus and disease are feasible.
A study of haplotypes of the TH/INS/IGF-II region constructed by statistical methods in unrelated Chinese Americans [17] , showed no statistically significant differences in haplotype frequencies between control and Type 2 diabetic subjects. In our study we found some haplotypes to be overrepresented in healthy subjects and some to be more common in Type 2 diabetic patients. However, the number of subjects carrying these haplotypes was too low to allow conclusive statistical evidence for an association with Type 2 diabetes.
Five different RFLP markers in the insulin gene region were used to investigate possible associations with Type 2 cently two studies were published where the problem of genetic heterogeneity was circumvented by screening for mutations in the insulin gene using the polymerase chain reaction [32, 33] . One approach to the problem of heterogeneity within the Type 2 diabetic group is to study association between DNA markers and variations in glucose metabolism. Since it is difficult to distinguish between primary and secondary derangements of glucose metabolism in the diabetic state, such studies should preferably be performed in healthy individuals. In our initial study, healthy subjects with certain PstI-A genotypes showed a more pronounced increase in the glucose concentrations during the early phase of the glucose infusion test. In order to confirm this finding, a follow-up study was performed on an additional group of 112 healthy subjects. Our initial finding could, however, not be confirmed. This illustrates the importance of follow-up studies on initial significant findings in genetic association studies.
We conclude from our data that (i) there is a high degree of linkage disequilibrium in the TH/INS/IGF-II region; (ii) no statistically significant association between haplotypes or genotypes and Type 2 diabetes could be demonstrated; and (iii) no significant association between genotypes and variations in glucose metabolism in healthy subjects could be demonstrated. Bearing the limits of population association studies in mind, our findings suggest that the TH/INS/IGF-II region is not likely to be the major susceptibility locus for common forms of Type 2 diabetes in non-obese Scandinavian subjects. However, due to the complexity of the disease, it is difficult to exclude a certain contribution of this locus for insulin deficiency and susceptibility to Type 2 diabetes.
